NUCB2 and psychotic disorder: In the Sahpolat and Ari study, patients had lower mean nesfatin-1 levels during the first episode of psychosis (0.60 ± 1.00 ng/mL) than controls (0.75 ± 1.07 ng/mL), but this was not a statistically significant difference.